Once-Daily Roflumilast Foam 0.3% Improves Severity and Burden of Itch in Patients With Scalp and Body Psoriasis in a Randomized, Double-blind, Vehicle-Controlled Phase 2b Study

Main Article Content

Angela Moore
Javier Alonso-Llamazares
Neal Bhatia
Alim Devani
Michael Bukhalo
Zoe Draelos
Melinda Gooderham
Steve Kempers
Leon Kircik
Kim Papp
David Pariser
Marina Sankeva
Rodney Sinclair
Matthew Zirwas
Amy Feng
Patrick Burnett
Robert Higham
David Berk

Keywords

roflumilast, foam, itch, psoriasis

Abstract

N/A

References

1. Chan CS, et al. J Am Acad Dermatol 2009;60:962-971.

2. Elewski B, et al. J Eur Acad Dermatol Venereol 2019;33:1465-1476.

3. Dopytalska K, et al. Reumatologia 2018;56:392-398.

4. Blakely K, Gooderham M. Psoriasis 2016;6:33-40.

5. Lebwohl MG, et al. N Engl J Med 2020;383:229-239

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 > >>